Dronabinol 2.5 MG

DRUG3 trials

Sponsors

Yale University, Charite University, Berlin, Germany, Incannex Healthcare Ltd

Conditions

Obstructive Sleep ApneaPost Traumatic Stress DisorderSickle Cell Disease

Phase 1

Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

TerminatedNCT03978156

Yale UniversitySickle Cell Disease

Start: 2019-07-26End: 2021-01-01Updated: 2021-01-26

Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs

CompletedNCT05857384

Incannex Healthcare LtdObstructive Sleep Apnea

Start: 2023-09-08End: 2024-07-31Updated: 2025-01-17

Unknown Phase

Activation of the Endocannabinoid System and Cognition

CompletedNCT05226351

Charite University, Berlin, GermanyPost Traumatic Stress Disorder

Start: 2022-03-01End: 2024-08-15Updated: 2025-03-10

Related Papers

A pilot study of dronabinol for the treatment of pain in sickle cell disease.

2025-11-12